SE8900899L - Peptider foer diagnostisk anvaendning - Google Patents

Peptider foer diagnostisk anvaendning

Info

Publication number
SE8900899L
SE8900899L SE8900899A SE8900899A SE8900899L SE 8900899 L SE8900899 L SE 8900899L SE 8900899 A SE8900899 A SE 8900899A SE 8900899 A SE8900899 A SE 8900899A SE 8900899 L SE8900899 L SE 8900899L
Authority
SE
Sweden
Prior art keywords
thr
glu
lys
gly
ile
Prior art date
Application number
SE8900899A
Other languages
Unknown language ( )
English (en)
Other versions
SE8900899D0 (sv
SE465573B (sv
Inventor
L Olson
Original Assignee
Lope Medicine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lope Medicine Ab filed Critical Lope Medicine Ab
Priority to SE8900899A priority Critical patent/SE465573B/sv
Publication of SE8900899D0 publication Critical patent/SE8900899D0/sv
Priority to PCT/SE1990/000149 priority patent/WO1990010644A1/en
Priority to AU53393/90A priority patent/AU5339390A/en
Publication of SE8900899L publication Critical patent/SE8900899L/sv
Publication of SE465573B publication Critical patent/SE465573B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
SE8900899A 1989-03-14 1989-03-14 Nervtillvaextfaktorpeptider, motsvarande antikroppar och foerfarande foer bestaemning av nativ nervtillvaextfaktor SE465573B (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE8900899A SE465573B (sv) 1989-03-14 1989-03-14 Nervtillvaextfaktorpeptider, motsvarande antikroppar och foerfarande foer bestaemning av nativ nervtillvaextfaktor
PCT/SE1990/000149 WO1990010644A1 (en) 1989-03-14 1990-03-08 Peptides and antibodies for the detection of ngf (nerve growth factor) and/or precursors thereof
AU53393/90A AU5339390A (en) 1989-03-14 1990-03-08 Peptides and antibodies for the detection of ngf (nerve growth factor) and/or precursors thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900899A SE465573B (sv) 1989-03-14 1989-03-14 Nervtillvaextfaktorpeptider, motsvarande antikroppar och foerfarande foer bestaemning av nativ nervtillvaextfaktor

Publications (3)

Publication Number Publication Date
SE8900899D0 SE8900899D0 (sv) 1989-03-14
SE8900899L true SE8900899L (sv) 1990-09-15
SE465573B SE465573B (sv) 1991-09-30

Family

ID=20375340

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900899A SE465573B (sv) 1989-03-14 1989-03-14 Nervtillvaextfaktorpeptider, motsvarande antikroppar och foerfarande foer bestaemning av nativ nervtillvaextfaktor

Country Status (3)

Country Link
AU (1) AU5339390A (sv)
SE (1) SE465573B (sv)
WO (1) WO1990010644A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1239270B (it) * 1990-02-27 1993-10-01 Fidia Spa Metodo per la determinazione quantitativa della forma biologicamente attiva del fattore di crescita nervoso umano in liquidi proteici
IT1243281B (it) * 1990-06-12 1994-05-26 Fidia Spa Metodo per la determinazione quantitativa e qualitativa di polipeptidiin liquidi proteici
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
ZA200504866B (en) 2002-12-24 2006-11-29 Rinat Neuroscience Corp Anti-ngf antibodies and methods using same
EP2364728A1 (en) 2003-07-15 2011-09-14 Amgen, Inc Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
ITRM20030601A1 (it) 2003-12-24 2005-06-25 Lay Line Genomics Spa Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
ITRM20050290A1 (it) 2005-06-07 2006-12-08 Lay Line Genomics Spa Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
KR20120088550A (ko) 2009-05-04 2012-08-08 애보트 리서치 비.브이. 증진된 생체내 안정성을 갖는 신경 성장 인자(ｎｇｆ)에 대한 항체

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009225A1 (en) * 1988-03-28 1989-10-05 The Regents Of The University Of California Nerve growth factor peptides

Also Published As

Publication number Publication date
AU5339390A (en) 1990-10-09
WO1990010644A1 (en) 1990-09-20
SE8900899D0 (sv) 1989-03-14
SE465573B (sv) 1991-09-30

Similar Documents

Publication Publication Date Title
BR0112602A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
BR0016066A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
DE69129302T2 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
DE3689941D1 (de) Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
ATE80951T1 (de) Immunoassays fuer denaturierte proteinanalyte, insbesondere hbalc und monoklonale antikoerper dafuer.
SE8900899D0 (sv) Peptides for diagnostic use
DE69433378D1 (de) Humane b-lymphoblastoiden zellinie welche anti-gangliosid-antikörper sekretiert
ES2079621T3 (es) Procedimiento de identificacion o de titulacion de proteinas y aplicaciones.
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
ATE151882T1 (de) Karzinomverwandtes haptoglobin (hpr)
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
ES2053712T3 (es) Un antigeno proteico reactivo y fragmentos del mismo.
DE69333560D1 (de) Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
ES2067024T3 (es) Metodo y kit para determinar actividades fosforilantes y desfosforilantes de tirosina.
HK1021229A1 (en) A in vitro method of determining the presence of aprotein in an isolated biological sample.
DE69529272T2 (de) MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA
DE69534263D1 (de) Expression kassette eines proteines p30 aus toxoplasma gondii
SE8704765L (sv) Immunologiskt aktiva polypeptider, anvendbara for framstellning av antimalariavacciner och diagnostest for pavisande av antisporozoantikroppar
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
DE3587542T2 (de) Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren.
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
DE69229948D1 (de) hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8900899-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8900899-9

Format of ref document f/p: F